Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme.
Clin Epigenetics. 2015 Mar 28;7(1):36. doi: 10.1186/s13148-015-0075-3. eCollection 2015.
Clin Epigenetics. 2015.
PMID: 25829971
Free PMC article.